Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

The women's sorority plans to donate $2 million by 2028 to St. Jude Children's Research Hospital, which offers care at no ...

Infections in sickle cell disease can be problematic and even fatal. Columnist Oluwatosin Adesoye, a patient and doctor, has ...

In honor of September's Sickle Cell Awareness Month, columnist Oluwatosin Adesoye shares her reasons for advocating for ...

Sickle cell carriers are at a slightly increased risk of blood clots, but the overall risk is still low, a study found.

A Nigerian hematologist will pursue a PhD in health policy at the University of Tennessee Health Science Center to help advance her work on programs for sickle cell disease (SCD) in her home country.